Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of <i>OPRM1</i> A/G Polymorphism on Its Effectiveness

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of <i>OPRM1</i> A/G Polymorphism on Its Effectiveness

Hypersexuality is a well-known adverse side effect of dopamine replacement therapy (DRT), and anti-craving drugs could be an effective therapeutic option. Our aim was to update the knowledge on this issue, particularly on the influence of an Opioid Receptor Mu 1 (<i>OPRM1</i>) genetic po...

Full description

Bibliographic Details
Main Authors: Audrey Verholleman, Caroline Victorri-Vigneau, Edouard Laforgue, Pascal Derkinderen, Celine Verstuyft, Marie Grall-Bronnec
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
Parkinson’s disease
dopamine replacement therapy
hypersexuality
impulse control disorder
sex addiction
naltrexone
Online Access:https://www.mdpi.com/1422-0067/21/8/3002

Internet

https://www.mdpi.com/1422-0067/21/8/3002

Similar Items